Kohnle M - Search Results

1

Metabolic factors have a major impact on kidney allograft survival.

Hamar P, Müller V, Kohnle M, Witzke O, Albrecht KH, Philipp T, Heemann U. Hamar P, et al. Among authors: kohnle m. Transplantation. 1997 Oct 27;64(8):1135-9. doi: 10.1097/00007890-199710270-00009. Transplantation. 1997. PMID: 9355829

2

Prevalence of diverticulosis and incidence of bowel perforation after kidney transplantation in patients with polycystic kidney disease.

Domínguez Fernández E, Albrecht KH, Heemann U, Kohnle M, Erhard J, Stöblen F, Eigler FW. Domínguez Fernández E, et al. Among authors: kohnle m. Transpl Int. 1998;11(1):28-31. doi: 10.1007/s001470050098. Transpl Int. 1998. PMID: 9503551

3

Conversion to tacrolimus in cyclosporin A treated patients with gum hyperplasia.

Kohnle M, Lütkes P, Witzke O, Philipp T, Heemann U. Kohnle M, et al. Transplant Proc. 1998 Aug;30(5):2122-3. doi: 10.1016/s0041-1345(98)00560-0. Transplant Proc. 1998. PMID: 9723413 Clinical Trial. No abstract available.

4

Anti-LFA-1 monoclonal antibody in renal transplantation: renal function, infections, and other complications.

Spillner J, Kohnle M, Albrecht KH, Heemann U. Spillner J, et al. Among authors: kohnle m. Transplant Proc. 1998 Aug;30(5):2163. doi: 10.1016/s0041-1345(98)00574-0. Transplant Proc. 1998. PMID: 9723427 Clinical Trial. No abstract available.

5

Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia.

Kohnle M, Zimmermann U, Lütkes P, Albrecht KH, Philipp T, Heemann U. Kohnle M, et al. Transpl Int. 2000;13 Suppl 1:S345-8. doi: 10.1007/s001470050358. Transpl Int. 2000. PMID: 11112029 Clinical Trial.

6

Quality of life after kidney transplantation--the impact of tacrolimus.

Reimer J, Franke GH, Luetkes P, Kohnle M, Philipp T, Heemann U. Reimer J, et al. Among authors: kohnle m. Transplant Proc. 2001 Feb-Mar;33(1-2):1924-6. doi: 10.1016/s0041-1345(00)02714-7. Transplant Proc. 2001. PMID: 11267573 No abstract available.

7

Impact of febrile infections on the long-term function of kidney allografts.

Witzke O, Schmidt C, Kohnle M, Lütkes P, Philipp T, Heemann U. Witzke O, et al. Among authors: kohnle m. J Urol. 2001 Dec;166(6):2048-52. J Urol. 2001. PMID: 11696704

8

[Quality of life following transplantation. The impact ofa new immunosuppressive substance].

Lütkes P, Franke G, Witzke O, Zimmermann U, Kohnle M, Philipp T, Heemann U. Lütkes P, et al. Among authors: kohnle m. Zentralbl Chir. 1999;124(2):90-4. Zentralbl Chir. 1999. PMID: 10209841 German.

9

Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia.

Kohnle M, Lütkes P, Zimmermann U, Philipp T, Heemann U. Kohnle M, et al. Transplant Proc. 1999 Nov;31(7A):44S-45S. doi: 10.1016/s0041-1345(99)00794-0. Transplant Proc. 1999. PMID: 10576043 Clinical Trial. No abstract available.

10

Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation.

Kohnle M, Pietruck F, Kribben A, Philipp T, Heemann U, Witzke O. Kohnle M, et al. Am J Transplant. 2006 Jan;6(1):205-8. doi: 10.1111/j.1600-6143.2005.01132.x. Am J Transplant. 2006. PMID: 16433776 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters